Skip to content

REACH-ASD Trial: A randomised controlled trial of a new workshop programme offering information, empowerment and emotional support to parents of children recently diagnosed with Autism Spectrum Disorder

REACH-ASD trial: a randomised controlled trial of psycho-education and acceptance & commitment therapy for parents of children recently diagnosed with ASD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN45412843
Enrollment
380
Registered
2019-09-11
Start date
2019-12-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health and well-being of parents/caregivers of children recently diagnosed with Autism Spectrum Disorder (ASD) Mental and Behavioural Disorders

Interventions

Randomisation to the intervention will be conducted through the online randomisation service of the King’s College London Clinical Trials Unit web-based randomisation service. Randomisation will be on
NHS or charity-led group interventions of varying intensities
individual needs-led interventions
or onward referral. Feedback from clinicians gives similar patterns of variation within the Greater Manchester region. These centre differences will be captured via detailed service-use data collectio
(ii) understanding and working with the education system
(iii) enabling your child’s communication and understanding
and (iv) understanding and managing emotions, behaviour and sensory needs. Parents are informed about

Sponsors

Manchester University NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 13/10/2020: 1. At consent, child aged between 2 years 0 months and 15 years 11 months. This is the age-range typically seen by ASD diagnostic teams. 2. At referral, child with a diagnosis of ASD from an NHS professional within the last 12 months. 3. One “index” adult (child’s parent/primary caregiver; must be aged 18 years or over) per child, nominated by family on “intention to participate” basis 4. Child with ASD is a patient of one of the trial collaborating centres Previous inclusion criteria: 1. At consent, child aged between 2 years 0 months and 15 years 11 months with a diagnosis of ASD from an NHS professional within the last 12 months. 2. One “index” adult (child’s parent/primary caregiver; must be aged 18 years or over) per child, nominated by family on “intention to participate” basis 3. Child with ASD is a patient of one of the trial collaborating centres

Exclusion criteria

Exclusion criteria: 1. Adult with insufficient English language to preclude participation 2. Adult with significant learning disability or significant hearing/visual impairment to preclude participation 3. Adult with current severe psychiatric condition to preclude participation 4. Significant current safeguarding concerns within family, identified by referring clinician

Design outcomes

Primary

MeasureTime frame
Parental mental health assessed using General Health Questionnaire- 30 at 1-year follow-up

Secondary

MeasureTime frame
Current secondary outcome measures as of 12/07/2022: Parent outcomes, measured at baseline and 12-, 26- and 52-week follow-up: 1. Parental ASD knowledge assessed using the Knowledge of Autism Questionnaire – UK 2. Parental wellbeing assessed using Warwick & Edinburgh Mental Wellbeing Scale 3. Parent health status assessed using EQ-5D-5L 4. Parental adjustment to diagnosis assessed using Reaction to Diagnosis Questionnaire 5. Parenting stress assessed using Autism Parenting Stress Index 6. Parenting self-efficacy assessed using Tool to measure Parenting Self Efficacy Family wellbeing and child functioning outcomes , measured at baseline and 52-week follow-up: 1. A parent-nominated self-report measure of family experience and wellbeing developed through parent consultation within previous trials (Autism Family Experience Questionnaire) 2. Expressed emotion as a blind-rated measure of family emotional climate (Autism Five Minute Speech Sample) 3. Child wellbeing assessed using Child Health Utility 9D Index 4. Child emotional and behaviour difficulties assessed using parent- and teacher (blind)-rated Strengths and Difficulties Questionnaire 5. Adaptive functioning assessed using parent(blind)-rated Vineland Adaptive Behaviour Scales _____ Previous secondary outcome measures: Parent outcomes, measured at baseline and 12-, 26- and 52-week follow-up: 1. Parental ASD knowledge assessed using Revised Autism Knowledge Survey 2. Parental wellbeing assessed using Warwick & Edinburgh Mental Wellbeing Scale 3. Parent health status assessed using EQ-5D-5L 4. Parental adjustment to diagnosis assessed using Reaction to Diagnosis Interview 5. Parenting stress assessed using Autism Parenting Stress Index 6. Parenting self-efficacy assessed using Tool to measure Parenting Self Efficacy Family wellbeing and child functioning outcomes , measured at baseline and 52-week follow-up: 1. A parent-nominated self-report measure of family experience and wellbeing developed through parent c

Countries

England, United Kingdom

Contacts

Public ContactKathy;Richard Leadbitter;Smallman

;

kathy.leadbitter@manchester.ac.uk;Richard.smallman@manchester.ac.uk+44 (0)161 275 5969;+44 (0)161 306 7943

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026